Journal of Young Pharmacists logo
Submit
Journal of Young PharmacistsACADEMIC PUBLISHING
Article

Repurposing of Drugs for Non-responding Erythema Nodosum Leprosum Cases - A Perspective

1★, 2, 3★ Corresponding author

  1. 1Department of Pharmacology, AIIMS, Raipur, Chhattisgarh, INDIA.
  2. 2Department of Pharmacology, AIIMS, Deogarh, Jharkhand, INDIA.
  3. 3Department of Microbiology, AIIMS, Raipur, Chhattisgarh, INDIA.

CORRESPONDENCE

Pugazhenthan Thangaraju

Department of Pharmacology, AIIMS, Raipur, Chhattisgarh, INDIA.

drpugal23@gmail.com

Received: 05-03-2022; Revised: 12-06-2022; Accepted: 24-06-2022.

Volume 14, Issue 3 · pp. 266-267 · 2022 · DOI: 10.5530/jyp.2022.14.53

ABSTRACT

Leprosy (Hansen’s disease) caused by Mycobacterium lepra is a debilitating tropical disease having maximal stigma till date. Efforts have been made for many decades to keep disease incidence under control. In 2019, 202,185 new cases of leprosy were reported around the world, with 14,981 (7.4%) of those found in children under the age of 15.1-3 Globally in 2020, 1, 28,405 new leprosy patients were diagnosed. New paediatric cases were 8661 diagnosed with leprosy and 7216 patients with grade 2 disability by WHO region.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Thangaraju, P., TY, S. S., & Venkatesan, S. (2022). Repurposing of Drugs for Non-responding Erythema Nodosum Leprosum Cases - A Perspective. Journal of Young Pharmacists, 14(3), 266-267. https://doi.org/10.5530/jyp.2022.14.53

    Copyright and licence

    © 2022 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0